MeSH D000437 - alcoholism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Disulfiram | Antabuse |  | 1982-01-01 |  |  |
| Ondansetron | Ondansetron |  | 2007-06-25 |  |  | |
| Naltrexone | Revia |  | 1984-11-20 |  |  | |
| Naltrexone | Naltrexone |  | 2023-07-06 |  |  | |
| Taro Pharmaceutical | Citalopram | Citalopram |  | 2006-03-22 |  |  |
| Ondansetron | Ondansetron |  | 2007-11-30 |  |  | |
| Glenmark Pharmaceuticals | Acamprosate | Acamprosate |  | 2013-07-16 |  |  |
| Citalopram | Citalopram |  | 2009-02-27 |  |  | |
| Ondansetron | Ondansetron |  | 2007-06-25 |  |  | |
| Mylan | Acamprosate | Acamprosate |  | 2014-03-11 |  |  |
| Citalopram | Citalopram |  | 2004-11-05 |  |  | |
| Ondansetron | Ondansetron |  | 2007-06-25 |  |  | |
| GSK | Ondansetron | Zofran |  | 1995-01-31 |  |  |
| Cipla | Citalopram | Citalopram |  | 2006-10-03 |  |  |
| Sandoz | Ondansetron | Ondansetron |  | 2007-06-27 |  |  |
| Ondansetron | Zofran |  | 1991-01-04 |  |  | |
| Cosette Pharmaceuticals | Citalopram | Citalopram |  | 2004-11-16 |  |  |
| Aurobindo Pharma | Citalopram | Citalopram |  | 2004-10-28 |  |  |
| Ondansetron | Ondansetron |  | 2007-07-31 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
74%34/46
Phase 2
47%42/90
Phase 3
65%26/40
Approved: 6Overall Success rate: 22%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use